Pediatr. praxi. 2023;24(5):299-303 | DOI: 10.36290/ped.2023.076

Hypophosphatasia and its differential diagnosis

doc. MUDr. Štěpán Kutílek, CSc.
Dětské oddělení a Osteocentrum Klatovské nemocnice, a. s., Klatovy

Hypophosphatasia (HPP) is a rare, inherited, metabolic disease characterized by disorders of calcium and phosphate metabolism, bone deformities, loss of teeth, recurrent fractures, growth retardation. HPP is caused by mutations of gene encoding tissue-non-specific alkaline phosphatase (TNSALP). Over 400 TNSALP mutations have been documented so far. The mutation results in TNSALP deficiency and leads to defective skeletal mineralization. There are six subtypes of HPP: Perinatal lethal HPP and Infantile HPP, both of which are lethal; Benign prenatal HPP, Childhood-onset HPP, Adult HPP and OdontoHPP with a better prognosis. Clinical manifestations of HPP are very diverse, ranging from severe skeletal deformities to asymptomatic course. It is essential to establish a proper diagnosis and distinguish from other skeletal disorders (rickets, osteogenesis imperfecta, osteopathy of prematurity, cleidocranial dysplasia, thanatoforic dysplasia, achondrogenesis/hypochondrogenesis, campomelic dysplasia, osteoporosis).

Keywords: alkaline phosphatase, bone, asfotase, hypophosphatasia.

Accepted: October 9, 2023; Published: October 13, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kutílek Š. Hypophosphatasia and its differential diagnosis. Pediatr. praxi. 2023;24(5):299-303. doi: 10.36290/ped.2023.076.
Download citation

References

  1. Villa-Suarez JM, Garcia-Fontana CG, Andujar-Vera F, et al. Hypophosphatasia: A unique disorder of bone mineralization. Int J Mol Sci. 2021;22:4303. Go to original source... Go to PubMed...
  2. Mornet E. Hypophosphatasia. Metabolism. 2018;82:142-155. Go to original source... Go to PubMed...
  3. Millan JL, Whyte MP. Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int. 2016;98:398-416. Go to original source... Go to PubMed...
  4. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev. 1994;15:439-461. Go to original source... Go to PubMed...
  5. Whyte MP. Hypophosphatasia. In: Scriver CR ed. The Metabolic Basis of Inherited Disease. McGraw-Hill 1995:4095-4111.
  6. Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12:233-246. Go to original source... Go to PubMed...
  7. Mornet E. Hypophosphatasia. Metabolism. 2017 Sep 20. pii: S0026-0495(17)30229-9. doi: 10.1016.
  8. Mornet E, Taillandier A, Domingues C, et al. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021;29:289-299. Go to original source... Go to PubMed...
  9. Mornet E. Genetics of hypophosphatasia. Arch Pediatr. 2017;24:5S51-5S56. Go to original source... Go to PubMed...
  10. Šumník Z, Souček O, Lebl J. Hypofosfatázie: Kdy na ni myslet a jak ji léčit. Pediatr. Praxi. 2016;17:37-40. Go to original source...
  11. Kutílek Š, Šumník Z. Hypofosfatázie - onemocnění skeletu, na které musíme myslet. Čes-slov Pediat. 2017;72:228-231.
  12. Moss DW. Alkaline phosphatase isoenzymes. Clin Chem. 1982;28:2007. Go to original source...
  13. Fauvert D, Brun-Heath I, Lia-Baldini AS, et al. Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet. 2009;10:51. Go to original source... Go to PubMed...
  14. Barvencik F, Beil FT, Gebauer M, et al. Skeletal mineralization defects in adult hypophosphatasia - a clinical and histological analysis. Osteoporos Int. 2011;22:2667-2675. Go to original source... Go to PubMed...
  15. Weber TJ, Sawyer EK, Moseley S, et al. Burden of disease in adult patients with hypophosphatasia: Results from two patient-reported surveys. Metabolism. 2016;65:1522-1530. Go to original source... Go to PubMed...
  16. Iqbal U, Anwar H, Chaudhary A, et al. Recurrent Metatarsal Fractures in Postmenopausal Woman With Low Serum Alkaline Phosphatase: A Rare Diagnosis Not to Miss. J Investig Med High Impact Case Rep. 2017;5:2324709617718851. doi: 10.1177/2324709617718851. eCollection 2017 Jul-Sep. Go to original source...
  17. Guañabens N, Blanch J, Martínez-Díaz-Guerra G, et al. Identification of hypophosphatasia in a clinical setting: Clinical manifestations and diagnostic recommendations in adult patients. Med Clin (Barc). 2017: S0025-7753(17)30527-4. doi: 10.1016/j.medcli.2017.06.040. [Epub ahead of print]. Go to original source... Go to PubMed...
  18. Braunstein NA. Multiple fractures, pain, and severe disability in a patient with adult-onset hypophosphatasia. Bone Rep. 2015;4:1-4. Go to original source... Go to PubMed...
  19. Schmidt T, Mussawy H, Rolvien T, et al. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int. 2017 May 25. doi: 10.1007/s00198-017-4087-z. Go to original source... Go to PubMed...
  20. Yavuz U, Sökücü S, Demir B, et al. An unusual stress fracture in an archer with hypophosphatasia. Case Rep Orthop. 2013;2013:1-3. Go to original source... Go to PubMed...
  21. Tenorio J, Álvarez I, Riancho-Zarrabeitia L, et al. Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia. Am J Med Genet. 2017;173:601-610. Go to original source... Go to PubMed...
  22. Hayashi-Sakai S, Numa-Kinjoh N, Sakamoto M, et al. Hypophosphatasia: Evaluation of Size and Mineral Density of Exfoliated Teeth. J Clin Pediatr Dent. 2016;40(6):496-502. Go to original source... Go to PubMed...
  23. Reibel A, Manière MC, Clauss F, et al. Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. Orphanet J Rare Dis. 2009 ;4:6. doi: 10.1186/1750-1172-4-6. Go to original source... Go to PubMed...
  24. Mori M, DeArmey SL, Weber TJ, et al. Case series: Odontohypophosphatasia or missed diagnosis of childhood/adult-onset hypophosphatasia? - Call for a long-term follow-up of premature loss of primary teeth. Bone Rep. 2016;5:228-232. Go to original source... Go to PubMed...
  25. Bangura A, Wright L, Shuler T Hypophosphatasia: Current Literature for Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment. Cureus. 2020;12:e8594. Go to original source... Go to PubMed...
  26. Borg SA, Bishop NJ. New diagnostic modalities and emerging treatments for neonatal bone disease. Early Hum Dev. 2018;126:32-37. Go to original source... Go to PubMed...
  27. Castells L, Cassanello P, Muñiz F, et al. Neonatal lethal hypophosphatasia: A case report and review of literature. Medicine (Baltimore). 2018;97:e13269. Go to original source... Go to PubMed...
  28. Offiah AC, Vockley J, Munns CF, et al. Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives. Pediatr Radiol. 2019;49:3-22. Go to original source... Go to PubMed...
  29. Whyte MP, Greenberg CR, Salman NJ, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012;366:904-913. Go to original source... Go to PubMed...
  30. Whyte MP, Rockman-Greenberg C, Ozono K, et al. Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endocrinol Metab. 2016;101:334-342. Go to original source... Go to PubMed...
  31. Kitaoka T, Tajima T, Nagasaki K, et al. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial. Clin Endocrinol (Oxf). 2017 Apr 4. doi: 10.1111/cen.13343. [Epub ahead of print]. Go to original source... Go to PubMed...
  32. Whyte MP. Hypophosphatasia: An overview for 2017. Bone. 2017 Feb 24. pii: S8756-3282(17)30056-X. doi: 10.1016/j.bone.2017.02.011. Go to original source... Go to PubMed...
  33. Whyte MP. Hypophosphatasia: Enzyme replacement therapy brings new opportunities and new challenges. J Bone Miner Res. 2017;32:667-675. doi: 10.1002/jbmr.3075. Epub 2017 Jan 31. Go to original source... Go to PubMed...
  34. Righetti M, Wach J, Desmarchelier R, et al. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures. Joint Bone Spine. 2017; pii: S1297-319X(17)30206-3. doi: 10.1016/j.jbspin.2017.12.001. Go to original source... Go to PubMed...
  35. Bhattacharyya T, Jha S, Wang H, et al. Hypophosphatasia and the risk of atypical femur fractures: a case-control study. BMC Musculoskelet Disord. 2016;17:332. doi: 10.1186/s12891-016-1191-8. Go to original source... Go to PubMed...
  36. Whyte MP. Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res. 2009;24:1132-1134. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.